ω-3 fatty acids infusions as adjuvant therapy in rheumatoid arthritis

Journal of Parenteral and Enteral Nutrition

Volumn 34, Issue 2, 2010, Pages 151-155

  Bahadori, Babak ^a,b   Uitz, Elisabeth ^a   Thonhofer, Rene ^a   Trummer, Markus ^a   Pestemer Lach, Iris ^b   McCarty, Mark ^c   Krejs, Guenter J ^d  

^a State Hospital Muerzzuschlag   (Austria)

^b Rheumatology and Metabolism Research Center   (Austria)

^c Pantox Laboratories   (United States)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Fatty acids; Fish oil; Omega 3 fatty acid; Rheumatoid arthritis; Unsaturated

Indexed keywords

C REACTIVE PROTEIN; METHOTREXATE; OMEGA 3 FATTY ACID; OMEGAVEN; PLACEBO; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE;

ANTIRHEUMATIC AGENTS; ARTHRALGIA; ARTHRITIS, RHEUMATOID; DIETARY FATS; DOUBLE-BLIND METHOD; EDEMA; EMULSIONS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; JOINTS; MALE; MIDDLE AGED; PARAFFIN; PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 77952573196     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109342130     Document Type: Article

References (28)

1. Lee DM, Weinblatt ME Rheumatoid arthritis. Lancet. 2001 ; 358: 903-911.
2. Spector TD Rheumatoid arthritis. Rheum Dis Clin North Am. 1990 ; 16: 513-537.
3. Silman AJ, Pearson JE Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002 ; 4 (suppl 3). S265 - S272.
4. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF The development of disability in rheumatoid arthritis. Arthritis Rheum. 1986 ; 29: 494-500.
5. Holm MB, Rogers JC, Kwoh CK Predictors of functional disability in patients with rheumatoid arthritis. Arthritis Care Res. 1998 ; 11: 346-355.
6. Turesson C., Matteson E. Management of extra-articular disease manifestations in rheumatoid arthritis. Curr Opin Rheumatol. 2004 ; 16: 206-211. (Pubitemid 38530487)
7. Langford RM Pain management today-what have we learned ? Clin Rheumatol. 2006 ; 25: 2-8.
8. Andersohn F., Suissa S., Garbe E. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation. 2006 ; 113: 1950-1957.
9. Choy EH, Smith C., Dore CJ, Scott DL A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology (Oxford). 2005 ; 44: 1414-1421.
10. Siddiqui MA The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence. Curr Opin Rheumatol. 2007 ; 19: 308-313.
11. Lo V., Meadows SE, Saseen J. When should COX-2 selective NSAIDs be used for osteoarthritis and rheumatoid arthritis ? J Fam Pract. 2006 ; 55: 260-262.
12. Kremer JM n-3 Fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr. 2007 ; 71 (suppl): 349s - 351s.
13. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007 ; 129: 210-223.
14. Leeb BF, Sautner J., Andel I., Rintelen B. Intravenous application of omega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study. Lipids. 2006 ; 41: 29-34.
15. Arnett FC, Edwarthy SM, Bloch DA, et al. The American Rheumatism Association 1987 Revised Criteria for the Classification of Rheumatoid Arthritis. Arthritis Rheum. 1988 ; 31: 315-324.
16. Sperling RI, Weinblatt M., Robin JL, et al. Effects of dietary supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum. 1987 ; 30: 988-997.
17. Cleland LF, French JK, Betts WH, Murphy GA, Elliott MJ Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol. 1988 ; 15: 1471-1475.
18. Belch JJF, Ansell D., Madhok R., Dowd AO, Sturrock RD Effects of altering dietary essential fatty acids on requirements for nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis. 1988 ; 47: 96-104.
19. Lau CS, Morley KD, Belch JJ Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double-blind placebo controlled study. Br J Rheumatol. 1993 ; 32: 982-989.
20. Trichopoulou A., Vasilopoulou E. Mediterranean diet and longevity. Br J Nutr. 2000 ; 84 (suppl 2). S205 - S209.
21. de Lorgeril M., Renaud S., Salen P., et al. Mediterranean a-linolenic acid rich diet in secondary prevention of coronary heart disease. Lancet. 1994 ; 343: 1454-1459.
22. Cleland LG, James MJ Fish oil and rheumatoid arthritis: antiinflammatory and collateral health benefits. J Rheumatol. 2000 ; 27: 2305-2307.
23. Zampelas A., Murphy M., Morgan LM, Williams CM Postprandial lipoprotein lipase, insulin and gastric inhibitory polypeptide responses to test meals of different fatty acid composition: comparison of saturated, n-6 and n-3 polyunsaturated fatty acids. Eur J Clin Nutr. 1994 ; 48: 849-858.
24. Oh R. Practical applications of fish oil (omega-3 fatty acids) in primary care. J Am Board Fam Pract. 2005 ; 18: 28-36.
25. De Caterina R., Massaro M. Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J Membr Biol. 2005 ; 206: 103-116.
26. Madsen T., Christensen JH, Blom M., Schmidt EB The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr. 2003 ; 89: 517-522.
27. Chan DC, Watts GF, Barrett PH, et al. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin Chem. 2002 ; 48: 877-883.
28. Hong H., Xu ZM, Pang BS, et al. Effects of simvastatin combined with omega-3 fatty acids on high sensitive C-reactive protein, lipidemia, and fibrinolysis in patients with mixed dyslipidemia. Chin Med Sci J. 2004 ; 19: 145-149.